334 related articles for article (PubMed ID: 1971019)
41. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
42. Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.
Lawrence DM; Joseph DB; Bidlack JM
Biochem Pharmacol; 1995 Jan; 49(1):81-9. PubMed ID: 7840787
[TBL] [Abstract][Full Text] [Related]
43. Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences.
Rothman RB; Bykov V; Xue BG; Xu H; De Costa BR; Jacobson AE; Rice KC; Kleinman JE; Brady LS
Peptides; 1992; 13(5):977-87. PubMed ID: 1336192
[TBL] [Abstract][Full Text] [Related]
44. Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes.
Gillan MG; Robson LE; McKnight AT; Kosterlitz HW
J Neurochem; 1985 Oct; 45(4):1034-42. PubMed ID: 2863329
[TBL] [Abstract][Full Text] [Related]
45. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
Morris BJ; Millan MJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
[TBL] [Abstract][Full Text] [Related]
46. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
[TBL] [Abstract][Full Text] [Related]
48. Biochemical characterization and regional quantification of mu, delta and kappa opioid binding sites in rat spinal cord.
Stevens CW; Lacey CB; Miller KE; Elde RP; Seybold VS
Brain Res; 1991 May; 550(1):77-85. PubMed ID: 1653636
[TBL] [Abstract][Full Text] [Related]
49. Localisation and pharmacological characterisation of [3H]bremazocine binding in the bovine adrenal medulla.
Bunn SJ
Neurosci Lett; 1991 Apr; 125(2):139-42. PubMed ID: 1652708
[TBL] [Abstract][Full Text] [Related]
50. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
51. Kappa-opioid receptors are differentially labeled by arylacetamides and benzomorphans.
Rusovici DE; Negus SS; Mello NK; Bidlack JM
Eur J Pharmacol; 2004 Feb; 485(1-3):119-25. PubMed ID: 14757131
[TBL] [Abstract][Full Text] [Related]
52. Focal stimulation of the mossy fibers releases endogenous dynorphins that bind kappa 1-opioid receptors in guinea pig hippocampus.
Wagner JJ; Evans CJ; Chavkin C
J Neurochem; 1991 Jul; 57(1):333-43. PubMed ID: 1675664
[TBL] [Abstract][Full Text] [Related]
53. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
Brent PJ
Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
[TBL] [Abstract][Full Text] [Related]
54. Comparison of kappa 2-opioid receptors in guinea pig brain and guinea pig ileum membranes.
Webster JL; Polgar WE; Brandt SR; Berzetei-Gurske IP; Toll L
Eur J Pharmacol; 1993 Feb; 231(2):251-8. PubMed ID: 8095898
[TBL] [Abstract][Full Text] [Related]
55. Opioid binding properties of the purified kappa receptor from human placenta.
Ahmed MS; Zhou DH; Cavinato AG; Maulik D
Life Sci; 1989; 44(13):861-71. PubMed ID: 2538693
[TBL] [Abstract][Full Text] [Related]
56. [3H]diprenorphine binding to kappa-sites in guinea-pig and rat brain: evidence for apparent heterogeneity.
Wood MS; Traynor JR
J Neurochem; 1989 Jul; 53(1):173-8. PubMed ID: 2542456
[TBL] [Abstract][Full Text] [Related]
57. The binding to rat brain homogenates of Mr2034, a universal opiate.
Johnson N; Pasternak GW
Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
[TBL] [Abstract][Full Text] [Related]
58. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
Chang KJ; Blanchard SG; Cuatrecasas P
Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
[TBL] [Abstract][Full Text] [Related]
59. Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic kappa-opioid agonists in rhesus monkeys.
Butelman ER; Ball JW; Kreek MJ
Psychoneuroendocrinology; 2004 Apr; 29(3):307-26. PubMed ID: 14644063
[TBL] [Abstract][Full Text] [Related]
60. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
Schmauss C
Eur J Pharmacol; 1987 Jun; 137(2-3):197-205. PubMed ID: 2886350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
